Amphastar Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMPH and other ETFs, options, and stocks.

About AMPH

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. 

CEO
Yong Feng Zhang
CEOYong Feng Zhang
Employees
1,976
Employees1,976
Headquarters
Rancho Cucamonga, California
HeadquartersRancho Cucamonga, California
Founded
1996
Founded1996
Employees
1,976
Employees1,976

AMPH Key Statistics

Market cap
878.37M
Market cap878.37M
Price-Earnings ratio
10.05
Price-Earnings ratio10.05
Dividend yield
Dividend yield
Average volume
824.97K
Average volume824.97K
High today
$20.08
High today$20.08
Low today
$18.94
Low today$18.94
Open price
$20.08
Open price$20.08
Volume
753.55K
Volume753.55K
52 Week high
$31.26
52 Week high$31.26
52 Week low
$18.94
52 Week low$18.94

Stock Snapshot

As of today, Amphastar Pharmaceuticals(AMPH) shares are valued at $18.99. The company's market cap stands at 878.37M, with a P/E ratio of 10.05.

On 2026-03-06, Amphastar Pharmaceuticals(AMPH) stock traded between a low of $18.94 and a high of $20.08. Shares are currently priced at $18.99, which is +0.3% above the low and -5.4% below the high.

The Amphastar Pharmaceuticals(AMPH)'s current trading volume is 753.55K, compared to an average daily volume of 824.97K.

During the past year, Amphastar Pharmaceuticals(AMPH) stock moved between $18.94 at its lowest and $31.26 at its peak.

During the past year, Amphastar Pharmaceuticals(AMPH) stock moved between $18.94 at its lowest and $31.26 at its peak.

AMPH News

TipRanks 56m
Amphastar Updates Executive Employment Agreements to Strengthen Leadership

Amphastar Pharmaceuticals ( (AMPH) ) just unveiled an update. On March 3, 2026, Amphastar Pharmaceuticals entered into new executive employment agreements with...

TipRanks 22h
Amphastar Pharmaceuticals Balances Growth Plans With Margin Risks

Amphastar Pharmaceuticals Inc ((AMPH)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 70% Off TipRanks Premium Unlock hedge f...

Analyst ratings

57%

of 7 ratings
Buy
42.9%
Hold
57.1%
Sell
0%

People also own

Based on the portfolios of people who own AMPH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.